Junyu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junyu Wang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Bing Wei
Emergency Medicine Clinical Research Center, Beijing Chaoyang Hospital, Capital Medical University, & Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, 100043, People’s Republic of China
8 shared publications Ye Zhang
Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital &Capital Medical University, Beijing, 100000, People’s Republic of China
5 shared publicationsJia Wang
Emergency Medical Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China
3 shared publicationsJun Yang
Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, & Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, People's Republic of China
3 shared publicationsLe Hu
Emergency Medical Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China
2 shared publicationsXiangqun Zhang
Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, & Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, China
2 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-13
β2-Microglobulin Induces Mitochondrial Dysfunction Accompanied by Bronchial Epithelial Cell Senescence
Purpose: β 2-microglobulin (β 2m) is the light-chain subunit of major histocompatibility complex class I (MHC I) molecules. Our group previously showed that β 2m contributes to emphysema development by inducing epithelial cell senescence. However, the mechanism linking β 2m to epithelial senescence remains unclear. Previous studies have reported mitochondrial dysfunction in senescent lung cells from patients with emphysema, suggesting a potential mechanistic pathway. This in vitro study used BEAS-2B human bronchial epithelial cells to evaluate whether exposure to β 2m is associated with mitochondrial dysfunction and a senescent phenotype. Methods: Human bronchial epithelial BEAS-2B cells were exposed in vitro for 48 hours to recombinant human β 2m or cigarette smoke extract (CSE). Cellular senescence was assessed by senescence-associated β-galactosidase (SA-β-gal) staining. Mitochondrial dysfunction was evaluated by measuring mitochondrial membrane potential (MMP), reactive oxygen species (ROS), mitochondrial ROS (mtROS), oxygen consumption rate (OCR), and real-time adenosine triphosphate (ATP) production rate. Cell proliferation and apoptosis were assessed using CCK-8 and Annexin V-FITC/PI assays, respectively. Results: β 2m and CSE increased SA-β-gal staining in BEAS-2B cells, indicating enhanced cellular senescence. β 2m and CSE also decreased MMP, increased ROS and mtROS levels, and reduced OCR, indicating mitochondrial dysfunction. In addition, β 2m and CSE reduced BEAS-2B cell proliferation and increased apoptosis. Conclusion: β 2m exposure was associated with mitochondrial dysfunction and a senescent phenotype in BEAS-2B cells, accompanied by reduced proliferation and increased apoptosis. These findings suggest that β 2m may contribute to epithelial aging in COPD/emphysema, although further mechanistic investigation and in vivo validation are required.
- 1 June 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-13
Open Accessβ2-Microglobulin Induces Mitochondrial Dysfunction Accompanied by Bronchial Epithelial Cell Senescence
Purpose: β 2-microglobulin (β 2m) is the light-chain subunit of major histocompatibility complex class I (MHC I) molecules. Our group previously showed that β 2m contributes to emphysema development by inducing epithelial cell senescence. However, the mechanism linking β 2m to epithelial senescence remains unclear. Previous studies have reported mitochondrial dysfunction in senescent lung cells from patients with emphysema, suggesting a potential mechanistic pathway. This in vitro study used BEAS-2B human bronchial epithelial cells to evaluate whether exposure to β 2m is associated with mitochondrial dysfunction and a senescent phenotype. Methods: Human bronchial epithelial BEAS-2B cells were exposed in vitro for 48 hours to recombinant human β 2m or cigarette smoke extract (CSE). Cellular senescence was assessed by senescence-associated β-galactosidase (SA-β-gal) staining. Mitochondrial dysfunction was evaluated by measuring mitochondrial membrane potential (MMP), reactive oxygen species (ROS), mitochondrial ROS (mtROS), oxygen consumption rate (OCR), and real-time adenosine triphosphate (ATP) production rate. Cell proliferation and apoptosis were assessed using CCK-8 and Annexin V-FITC/PI assays, respectively. Results: β 2m and CSE increased SA-β-gal staining in BEAS-2B cells, indicating enhanced cellular senescence. β 2m and CSE also decreased MMP, increased ROS and mtROS levels, and reduced OCR, indicating mitochondrial dysfunction. In addition, β 2m and CSE reduced BEAS-2B cell proliferation and increased apoptosis. Conclusion: β 2m exposure was associated with mitochondrial dysfunction and a senescent phenotype in BEAS-2B cells, accompanied by reduced proliferation and increased apoptosis. These findings suggest that β 2m may contribute to epithelial aging in COPD/emphysema, although further mechanistic investigation and in vivo validation are required.
- Open Access
- 1 May 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 6427-6437
Machine Learning-Based Mortality Risk Prediction Model in Patients with Sepsis
Objective: The aim of our study was to establish and validate a machine learning-based predictive model for mortality risk in elderly patients with sepsis. By integrating traditional biomarkers, novel biomarkers, clinical data, and established scoring systems, the model seeks to enhance predictive accuracy and thereby improve clinical outcomes in high-risk patient population. Methods: Conducted at Beijing Chao-Yang Hospital from August 2021 to August 2023, our study included 180 emergency department patients meeting Sepsis 3.0 diagnostic criteria. Data collected included patient demographics, vital signs, laboratory parameters, disease-related scores, major comorbidities, and the 28-day mortality. Variables were analyzed using univariate analysis and LASSO regression, and the machine learning model was constructed using R statistical software and validated internally via bootstrap resampling and calibration curves. Results: The model identified seven significant variables: SOFA, APACHE II, MAP, ALB, PCT, LTB, and VEGF. These variables constituted our final prediction model, which achieved an AUC of 0.845 (95% CI: 0.786, 0.905), with a sensitivity of 75.9% and a specificity of 85.0%. Internal validation yielded a bootstrap-corrected AUC of 0.857 (95% CI: 0.799, 0.912), confirming the model’s statistical robustness. The nomogram provided a visual tool for predicting 28-day mortality risk, and decision curve analysis demonstrated strong potential for clinical utility. Conclusion: The predictive model, which incorporates SOFA, APACHE II, MAP, ALB, PCT, LTB, and VEGF, shows significant potential in predicting the 28-day mortality risk for elderly sepsis patients. It provides a convenient and rapid tool for clinical use. Further research with larger sample sizes and external validation is warranted to confirm these findings and enhance the model’s applicability.
- 1 May 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 6427-6437
Open AccessMachine Learning-Based Mortality Risk Prediction Model in Patients with Sepsis
Objective: The aim of our study was to establish and validate a machine learning-based predictive model for mortality risk in elderly patients with sepsis. By integrating traditional biomarkers, novel biomarkers, clinical data, and established scoring systems, the model seeks to enhance predictive accuracy and thereby improve clinical outcomes in high-risk patient population. Methods: Conducted at Beijing Chao-Yang Hospital from August 2021 to August 2023, our study included 180 emergency department patients meeting Sepsis 3.0 diagnostic criteria. Data collected included patient demographics, vital signs, laboratory parameters, disease-related scores, major comorbidities, and the 28-day mortality. Variables were analyzed using univariate analysis and LASSO regression, and the machine learning model was constructed using R statistical software and validated internally via bootstrap resampling and calibration curves. Results: The model identified seven significant variables: SOFA, APACHE II, MAP, ALB, PCT, LTB, and VEGF. These variables constituted our final prediction model, which achieved an AUC of 0.845 (95% CI: 0.786, 0.905), with a sensitivity of 75.9% and a specificity of 85.0%. Internal validation yielded a bootstrap-corrected AUC of 0.857 (95% CI: 0.799, 0.912), confirming the model’s statistical robustness. The nomogram provided a visual tool for predicting 28-day mortality risk, and decision curve analysis demonstrated strong potential for clinical utility. Conclusion: The predictive model, which incorporates SOFA, APACHE II, MAP, ALB, PCT, LTB, and VEGF, shows significant potential in predicting the 28-day mortality risk for elderly sepsis patients. It provides a convenient and rapid tool for clinical use. Further research with larger sample sizes and external validation is warranted to confirm these findings and enhance the model’s applicability.
- Open Access
- 1 November 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 9837-9846
Predictive Value of SYN-1 Levels for Mortality in Sepsis Patients in the Emergency Department
Objective: To evaluate and predict adverse outcomes associated with serum Syndecan-1 (SYN-1) levels in patients with early sepsis, and to explore the prognostic risk factors in sepsis and septic shock. Methods: This retrospective single-center observational study included 168 sepsis patients admitted to the Emergency Department of Beijing Chao-Yang Hospital Shijingshan Branch, Capital Medical University, from October 2020 to October 2021. Patients were categorized into sepsis (n=114) and septic shock (n=54) groups based on Sepsis 3.0 criteria. They were further divided into survival (n=128) and death (n=40) groups. Comparative analyses included general demographics and laboratory findings (SYN-1, lactic acid [LAC], procalcitonin [PCT], C-reactive protein [CRP]) within 3 hours of admission, as well as Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores. Statistical methods included receiver operating characteristic (ROC) curve analysis, correlation analysis, and logistic regression. Results: Serum SYN-1 levels were significantly higher in the septic shock group (138.89± 9.26) compared to the sepsis group (102.89± 8.97) (P < 0.05). SYN-1 levels were also significantly higher in the death group (150.19± 7.65) compared to the survival group (103.301± 86.59) (P < 0.05). The area under the ROC curves for SYN-1, LAC, and APACHE II scores in predicting 28-day mortality were 0.668, 0.641, and 0.666, respectively. SYN-1 showed a positive correlation with SOFA scores (correlation coefficient=0.228). SYN-1, APACHE II score, and LAC were identified as independent risk factors for 28-day mortality in sepsis patients. Conclusion: SYN-1 demonstrates high sensitivity and specificity in early prediction of poor outcomes in sepsis patients. SYN-1, APACHE II score, and LAC serve as independent risk factors for 28-day mortality in sepsis patients.
- 1 November 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 9837-9846
Open AccessPredictive Value of SYN-1 Levels for Mortality in Sepsis Patients in the Emergency Department
Objective: To evaluate and predict adverse outcomes associated with serum Syndecan-1 (SYN-1) levels in patients with early sepsis, and to explore the prognostic risk factors in sepsis and septic shock. Methods: This retrospective single-center observational study included 168 sepsis patients admitted to the Emergency Department of Beijing Chao-Yang Hospital Shijingshan Branch, Capital Medical University, from October 2020 to October 2021. Patients were categorized into sepsis (n=114) and septic shock (n=54) groups based on Sepsis 3.0 criteria. They were further divided into survival (n=128) and death (n=40) groups. Comparative analyses included general demographics and laboratory findings (SYN-1, lactic acid [LAC], procalcitonin [PCT], C-reactive protein [CRP]) within 3 hours of admission, as well as Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores. Statistical methods included receiver operating characteristic (ROC) curve analysis, correlation analysis, and logistic regression. Results: Serum SYN-1 levels were significantly higher in the septic shock group (138.89± 9.26) compared to the sepsis group (102.89± 8.97) (P < 0.05). SYN-1 levels were also significantly higher in the death group (150.19± 7.65) compared to the survival group (103.301± 86.59) (P < 0.05). The area under the ROC curves for SYN-1, LAC, and APACHE II scores in predicting 28-day mortality were 0.668, 0.641, and 0.666, respectively. SYN-1 showed a positive correlation with SOFA scores (correlation coefficient=0.228). SYN-1, APACHE II score, and LAC were identified as independent risk factors for 28-day mortality in sepsis patients. Conclusion: SYN-1 demonstrates high sensitivity and specificity in early prediction of poor outcomes in sepsis patients. SYN-1, APACHE II score, and LAC serve as independent risk factors for 28-day mortality in sepsis patients.
- Open Access
Predictive value of IL-8 for mortality risk in elderly sepsis patients of emergency department
- Open Access
- 1 March 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 1503-1509
Prognostic Value of Macrophage Inflammatory Protein-3alpha (MIP3-Alpha) and Severity Scores in Elderly Patients with Sepsis
Objective: This study examines the effectiveness of MIP-3alpha and severity scores in determining the prognosis of elderly sepsis patients. Methods: From October 2020 to April 2021, a total of 171 elderly sepsis patients were admitted to the Emergency Department of the Shijingshan Branch of Beijing Chaoyang Hospital, Capital Medical University. According to the 28-day mortality rate, they were divided into two groups: survivors (48 cases) and deaths (123 cases). At admission, severity scores which are the Sequential Organ Failure Assessment (SOFA) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) were calculated. The logistic regression was used to analyze the independent risk factors associated with 28-day mortality in elderly sepsis patients. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were used to evaluate the value of MIP-3alpha, SOFA, and APACHE II in the evaluation of 28-day mortality in elderly sepsis patients. Results: MIP-3alpha, SOFA and APACHE II of the death group were significantly higher than those of the survival group (P < 0.05). Multivariate logistic regression analysis showed that MIP-3alpha, SOFA, APACHE II, and systolic blood pressure (SBP) were independent risk factors for 28-day mortality of senile sepsis (P < 0.05). Analysis of the ROC curve revealed that MIP-3alpha, SOFA, APACHE II had predictive value for the 28-day prognosis of senile sepsis (all P < 0.01). Combing with MIP-3alpha and SOFA showed better predictive ability (Z1 = 3.733, Z2 = 2.996, both P < 0.01), compared to detecting MIP-3alpha and SOFA alone. Conclusion: In senile sepsis, MIP-3alpha, SOFA, APACHE II and SBP are independent risk factors for 28-day mortality. The combination of MIP-3alpha and SOFA can further enhance the predictive value of 28-day mortality in patients with senile sepsis and provide some reference value for the evaluation and treatment of senile sepsis.
- 1 March 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 1503-1509
Open AccessPrognostic Value of Macrophage Inflammatory Protein-3alpha (MIP3-Alpha) and Severity Scores in Elderly Patients with Sepsis
Objective: This study examines the effectiveness of MIP-3alpha and severity scores in determining the prognosis of elderly sepsis patients. Methods: From October 2020 to April 2021, a total of 171 elderly sepsis patients were admitted to the Emergency Department of the Shijingshan Branch of Beijing Chaoyang Hospital, Capital Medical University. According to the 28-day mortality rate, they were divided into two groups: survivors (48 cases) and deaths (123 cases). At admission, severity scores which are the Sequential Organ Failure Assessment (SOFA) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) were calculated. The logistic regression was used to analyze the independent risk factors associated with 28-day mortality in elderly sepsis patients. The receiver operating characteristic (ROC) curve and area under the curve (AUC) were used to evaluate the value of MIP-3alpha, SOFA, and APACHE II in the evaluation of 28-day mortality in elderly sepsis patients. Results: MIP-3alpha, SOFA and APACHE II of the death group were significantly higher than those of the survival group (P < 0.05). Multivariate logistic regression analysis showed that MIP-3alpha, SOFA, APACHE II, and systolic blood pressure (SBP) were independent risk factors for 28-day mortality of senile sepsis (P < 0.05). Analysis of the ROC curve revealed that MIP-3alpha, SOFA, APACHE II had predictive value for the 28-day prognosis of senile sepsis (all P < 0.01). Combing with MIP-3alpha and SOFA showed better predictive ability (Z1 = 3.733, Z2 = 2.996, both P < 0.01), compared to detecting MIP-3alpha and SOFA alone. Conclusion: In senile sepsis, MIP-3alpha, SOFA, APACHE II and SBP are independent risk factors for 28-day mortality. The combination of MIP-3alpha and SOFA can further enhance the predictive value of 28-day mortality in patients with senile sepsis and provide some reference value for the evaluation and treatment of senile sepsis.
- Open Access
- 14 November 2023
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 29, e942079-e942079-8
Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 (MCP-1) and 28-Day Mortality in Elderly Patients with Sepsis: A Retrospective Single-Center Study
Background: Previous studies have identified an association between plasma levels of the inflammatory cytokine, monocyte chemoattractant protein-1 (MCP-1), and outcomes for patients with sepsis. This retrospective single-center study assessed the association between plasma levels of MCP-1 and 28-day mortality in 136 patients 365 years diagnosed with sepsis between October 2020 and October 2021. Material/Methods: The objective was to compare and analyze the parameters in the survival group (n=35) and the 28-day mortality group (n=101), including Sequential Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health Evaluation II (APACHE II), plasma MCP-1, and laboratory test results. Plasma MCP-1 was quantified by cytokine test kit (LKTM014B, R&D). Statistical analysis was carried out in SPSS 26.0 and MedCalc 92.1.0 software. Results: The 28-day mortality group exhibited higher levels of SOFA, APACHEII, and plasma MCP-1 (all P<0.001), as well as lower levels of albumin, compared to the survival group (P<0.05). The logistic regression analysis findings indicated that SOFA, APACHEII, plasma MCP-1, and SBP are all independent risk factors for 28-day mortality. The area under the curve for SOFA, APACHEII, MCP-1, MCP-1+ SOFA, and MCP-1+APACHEII were 0.845, 0.744, 0.712, 0.879, and 0.822, respectively. MCP-1+SOFA exhibited higher sensitivity than SOFA alone. Furthermore, the assessment values of plasma MCP-1 combined with SOFA were superior to those of APACHE II or plasma MCP-1 (Z1=2.661, Z2=3.272, both P<0.01). Conclusions: The findings from this study from a single center support those of previous studies that increased plasma levels of MCP-1 are significantly associated with 28-day mortality in patients with sepsis.
- 14 November 2023
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 29, e942079-e942079-8
Open AccessAssociation Between Plasma Levels of Monocyte Chemoattractant Protein-1 (MCP-1) and 28-Day Mortality in Elderly Patients with Sepsis: A Retrospective Single-Center Study
Background: Previous studies have identified an association between plasma levels of the inflammatory cytokine, monocyte chemoattractant protein-1 (MCP-1), and outcomes for patients with sepsis. This retrospective single-center study assessed the association between plasma levels of MCP-1 and 28-day mortality in 136 patients 365 years diagnosed with sepsis between October 2020 and October 2021. Material/Methods: The objective was to compare and analyze the parameters in the survival group (n=35) and the 28-day mortality group (n=101), including Sequential Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health Evaluation II (APACHE II), plasma MCP-1, and laboratory test results. Plasma MCP-1 was quantified by cytokine test kit (LKTM014B, R&D). Statistical analysis was carried out in SPSS 26.0 and MedCalc 92.1.0 software. Results: The 28-day mortality group exhibited higher levels of SOFA, APACHEII, and plasma MCP-1 (all P<0.001), as well as lower levels of albumin, compared to the survival group (P<0.05). The logistic regression analysis findings indicated that SOFA, APACHEII, plasma MCP-1, and SBP are all independent risk factors for 28-day mortality. The area under the curve for SOFA, APACHEII, MCP-1, MCP-1+ SOFA, and MCP-1+APACHEII were 0.845, 0.744, 0.712, 0.879, and 0.822, respectively. MCP-1+SOFA exhibited higher sensitivity than SOFA alone. Furthermore, the assessment values of plasma MCP-1 combined with SOFA were superior to those of APACHE II or plasma MCP-1 (Z1=2.661, Z2=3.272, both P<0.01). Conclusions: The findings from this study from a single center support those of previous studies that increased plasma levels of MCP-1 are significantly associated with 28-day mortality in patients with sepsis.
- Open Access
- 27 December 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-6
Predictive Value of Heart-Type Fatty Acid-Binding Protein for Mortality Risk in Critically Ill Patients
Objective. Our study assessed the predictive value of heart-type fatty acid-binding protein (H-FABP) for critically ill patients. Methods. 150 critically ill patients admitted to the emergency department of Beijing Chaoyang Hospital, Capital Medical University, were included in our study from August 2021 to April 2022. Serum H-FABP, procalcitonin (PCT), lactate (LAC), and other markers were determined within 1 h after admission. The Sequential Organ Failure Assessment (SOFA) score and the Acute Physiology and Chronic Health Evaluation II (APACHE II) were calculated. The independent predictors of 28-day mortality in critically ill patients were analyzed by logistic regression, and the receiver operating characteristic curve (ROC) was used to analyze the predictive value for 28-day mortality in critically ill patients. Results. Age, APACHE II, SOFA, GCS, LAC, H-FABP, IL-6, Scr, and D-dimer were significantly different in the nonsurvivor vs. survivor groups ( ), with H-FABP correlating with cTNI, Scr, PCT, and SOFA scores ( ). Logistic regression analysis showed that H-FABP, APACHE II, LAC, and age were independent predictors for 28-day mortality in critically ill patients ( ). The AUC of ROC curve in H-FABP was 0.709 (sensitivity 72.9%, specificity 66.1%, and cut-off 4.35), which was slightly lower than AUC of ROC curve in LAC (AUC 0.750, sensitivity 58.3%, specificity 76.1%, and cut-off 1.95) and APACHE II (AUC 0.731, sensitivity 77.1%, specificity 58.7%, and cut-off 12.5). However, statistically, there was no difference in the diagnostic value of H-FABP compared with the other two indicators ( , ; , ). But H-FABP (72.9%) has higher sensitivity than LAC (58.3%). The combined evaluation of H-FABP+APACHE II score (AUC 0.801, sensitivity 71.7%, and specificity 78.2%; , ) had better diagnostic value than H-FABP alone and had high sensitivity (71.7%) and specificity (78.2%). Conclusion. H-FABP, LAC, APACHE II, and age can be used as independent risk factors affecting the prognosis of critically ill patients. Compared with using the above indicators alone, the H-FABP+APACHE II has a high diagnostic value, and the early and rapid evaluation is particularly important for the adjustment of treatment plans and prognosis.
- 27 December 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-6
Open AccessPredictive Value of Heart-Type Fatty Acid-Binding Protein for Mortality Risk in Critically Ill Patients
Objective. Our study assessed the predictive value of heart-type fatty acid-binding protein (H-FABP) for critically ill patients. Methods. 150 critically ill patients admitted to the emergency department of Beijing Chaoyang Hospital, Capital Medical University, were included in our study from August 2021 to April 2022. Serum H-FABP, procalcitonin (PCT), lactate (LAC), and other markers were determined within 1 h after admission. The Sequential Organ Failure Assessment (SOFA) score and the Acute Physiology and Chronic Health Evaluation II (APACHE II) were calculated. The independent predictors of 28-day mortality in critically ill patients were analyzed by logistic regression, and the receiver operating characteristic curve (ROC) was used to analyze the predictive value for 28-day mortality in critically ill patients. Results. Age, APACHE II, SOFA, GCS, LAC, H-FABP, IL-6, Scr, and D-dimer were significantly different in the nonsurvivor vs. survivor groups ( ), with H-FABP correlating with cTNI, Scr, PCT, and SOFA scores ( ). Logistic regression analysis showed that H-FABP, APACHE II, LAC, and age were independent predictors for 28-day mortality in critically ill patients ( ). The AUC of ROC curve in H-FABP was 0.709 (sensitivity 72.9%, specificity 66.1%, and cut-off 4.35), which was slightly lower than AUC of ROC curve in LAC (AUC 0.750, sensitivity 58.3%, specificity 76.1%, and cut-off 1.95) and APACHE II (AUC 0.731, sensitivity 77.1%, specificity 58.7%, and cut-off 12.5). However, statistically, there was no difference in the diagnostic value of H-FABP compared with the other two indicators ( , ; , ). But H-FABP (72.9%) has higher sensitivity than LAC (58.3%). The combined evaluation of H-FABP+APACHE II score (AUC 0.801, sensitivity 71.7%, and specificity 78.2%; , ) had better diagnostic value than H-FABP alone and had high sensitivity (71.7%) and specificity (78.2%). Conclusion. H-FABP, LAC, APACHE II, and age can be used as independent risk factors affecting the prognosis of critically ill patients. Compared with using the above indicators alone, the H-FABP+APACHE II has a high diagnostic value, and the early and rapid evaluation is particularly important for the adjustment of treatment plans and prognosis.
- Open Access
- 2 November 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 6441-6450
A Prognostic Model for In-Hospital Mortality in Critically Ill Patients with Pneumonia
Purpose: To determine the utility of a novel serum biomarker for the outcome prediction of critically ill patients with pneumonia. Patients and Methods: A retrospective analysis of critically ill patients was performed at an emergency department. The expression and prediction value of parameters were assessed. Binary logistic regression analysis was utilized to determine the indicators associated with in-hospital mortality of pneumonia patients. The Last Absolute Shrinkage and Selection Operator was used to further determine the independent predictors, which were validated by multiple logistic regression. The receiver operator characteristic curve was performed to assess their prediction values. A prognostic nomogram model was finally established for the outcome prediction for critically ill patients with pneumonia. Results: Retinol-binding protein (RBP) was significantly reduced in non-survived and pneumonia patients. CURB-65 score, levels of RBP, and blood urea nitrogen (BUN) were associated with in-hospital mortality of critically ill patients with pneumonia. Their combination was determined to be an ideal prognostic predictor (area under the curve of 0.762) and further developed into a nomogram prediction model (c-index 0.764). Conclusion: RBP is a novel in-hospital mortality predictor, which well supplements the CURB-65 score for critical pneumonia patients.
- 2 November 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 6441-6450
Open AccessA Prognostic Model for In-Hospital Mortality in Critically Ill Patients with Pneumonia
Purpose: To determine the utility of a novel serum biomarker for the outcome prediction of critically ill patients with pneumonia. Patients and Methods: A retrospective analysis of critically ill patients was performed at an emergency department. The expression and prediction value of parameters were assessed. Binary logistic regression analysis was utilized to determine the indicators associated with in-hospital mortality of pneumonia patients. The Last Absolute Shrinkage and Selection Operator was used to further determine the independent predictors, which were validated by multiple logistic regression. The receiver operator characteristic curve was performed to assess their prediction values. A prognostic nomogram model was finally established for the outcome prediction for critically ill patients with pneumonia. Results: Retinol-binding protein (RBP) was significantly reduced in non-survived and pneumonia patients. CURB-65 score, levels of RBP, and blood urea nitrogen (BUN) were associated with in-hospital mortality of critically ill patients with pneumonia. Their combination was determined to be an ideal prognostic predictor (area under the curve of 0.762) and further developed into a nomogram prediction model (c-index 0.764). Conclusion: RBP is a novel in-hospital mortality predictor, which well supplements the CURB-65 score for critical pneumonia patients.
- Open Access
- 26 October 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 6189-6202
Predictive Value of Combination of Procalcitonin and Predisposition, Infection, Response, and Organ Dysfunction (PIRO) System in Septic Patients with Positive Blood Cultures in the Emergency Department
Purpose: Procalcitonin and predisposition, infection, response, and organ dysfunction (PIRO) system have high predictive value for the prognosis of critically ill patients. There are few studies on the predictive value of patients with positive blood cultures. The aim of the study was to evaluate risk stratification and sepsis-related mortality in patients with positive blood cultures via procalcitonin (PCT) combined with the PIRO system in emergency departments (ED). Methods: A total of 1074 patients with positive blood cultures were admitted to Beijing Chao-Yang Hospital ED from December 2017 to October 2020. Their serum PCT was recorded, along with a Sequential Organ Failure Assessment (SOFA) score, Mortality in Emergency Department Sepsis (MEDS) score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and PIRO score to predict the prognosis of septic patients with positive blood culture in terms of ICU (intensive care unit) admission, multiple organ dysfunction syndrome (MODS) development, and 28-day mortality. Receiver operating characteristic (ROC) curves and logistic regression analysis were used to assess the prognostic value of the scoring systems. Results: A total of 978 patients met the inclusion criteria. PCT, MEDS, APACHE II, and PIRO scores were found to independently predict ICU-admission, MODS development, and 28-day mortality (P< 0.05), whereas SOFA did not. The AUC values of the PCT, MEDS, APACHE II, and PIRO scores for ICU-admission were 0.620, 0.740, 0.780, and 0.751, respectively. In the prediction of 28-day mortality, the AUC values of PCT, MEDS, APACHE II, and PIRO were 0.782, 0.745, 0.805, and 0.831, respectively. The AUC values combined PCT and PIRO system in predicting MODS and 28-day mortality were better than when predicting ICU-admission. Conclusion: This study indicates that PCT combined with the PIRO scoring system has a higher predictive value and is superior in predicting MODS and 28-day mortality in septic patients with positive blood cultures.
- 26 October 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 6189-6202
Open AccessPredictive Value of Combination of Procalcitonin and Predisposition, Infection, Response, and Organ Dysfunction (PIRO) System in Septic Patients with Positive Blood Cultures in the Emergency Department
Purpose: Procalcitonin and predisposition, infection, response, and organ dysfunction (PIRO) system have high predictive value for the prognosis of critically ill patients. There are few studies on the predictive value of patients with positive blood cultures. The aim of the study was to evaluate risk stratification and sepsis-related mortality in patients with positive blood cultures via procalcitonin (PCT) combined with the PIRO system in emergency departments (ED). Methods: A total of 1074 patients with positive blood cultures were admitted to Beijing Chao-Yang Hospital ED from December 2017 to October 2020. Their serum PCT was recorded, along with a Sequential Organ Failure Assessment (SOFA) score, Mortality in Emergency Department Sepsis (MEDS) score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and PIRO score to predict the prognosis of septic patients with positive blood culture in terms of ICU (intensive care unit) admission, multiple organ dysfunction syndrome (MODS) development, and 28-day mortality. Receiver operating characteristic (ROC) curves and logistic regression analysis were used to assess the prognostic value of the scoring systems. Results: A total of 978 patients met the inclusion criteria. PCT, MEDS, APACHE II, and PIRO scores were found to independently predict ICU-admission, MODS development, and 28-day mortality (P< 0.05), whereas SOFA did not. The AUC values of the PCT, MEDS, APACHE II, and PIRO scores for ICU-admission were 0.620, 0.740, 0.780, and 0.751, respectively. In the prediction of 28-day mortality, the AUC values of PCT, MEDS, APACHE II, and PIRO were 0.782, 0.745, 0.805, and 0.831, respectively. The AUC values combined PCT and PIRO system in predicting MODS and 28-day mortality were better than when predicting ICU-admission. Conclusion: This study indicates that PCT combined with the PIRO scoring system has a higher predictive value and is superior in predicting MODS and 28-day mortality in septic patients with positive blood cultures.
- Open Access
- 21 September 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 5557-5566
Diagnostic and Prognostic Value of Interleukin-6 in Emergency Department Sepsis Patients
Purpose: The objective of this study was to explore the diagnostic and prognostic value of interleukin-6 (IL-6) in sepsis patients presenting to the emergency department. Patients and Methods: A total of 128 patients who visited the emergency department of West Hospital of Beijing Chaoyang Hospital, affiliated to Capital Medical University, from November 2021 to February 2022 were subjected to this study. According to Sepsis-3.0 diagnostic criteria for sepsis, patients were divided into non-sepsis group (65 cases) and sepsis group (63 cases). Demographic data and clinical characteristics of the two patient groups were compared. Serum levels of biomarkers including IL-6, blood urea nitrogen (BUN), and lactic acid (Lac) were compared with Sequential Organ Failure Assessment (SOFA) and Glasgow Coma Scale (GCS) scores. Logistic regression was used to analyze independent risk factors and Receiver Operating Characteristic Curve (ROC) method was used to analyze the Area Under the Curve (AUC) to determine the diagnostic and prognostic value of markers. Results: Compared with non-sepsis patients, levels of IL-6, PCT, CRP and BUN were significantly higher in sepsis patients (10.84 (4.41– 27.01): 92.22 (21.53– 201.12), 0.03 (0.01– 0.1):0.49 (0.08– 3.1), 8.3 (0.5– 31.8):39.8(10.3– 98.6), 7.01 (4.90– 11.74):13.03 (6.93– 25.99), all p = 0.001). IL-6, BUN and mean arterial pressure (MAP) were independent risk factors for sepsis diagnosis. AUC values of IL-6, BUN, MAP and IL-6+BUN+MAP were 0.764, 0.696, 0.685, and 0.848, respectively. Lactate, age and SOFA score were independent risk factors for 28-day mortality in sepsis patients. The AUC of Lac, age, SOFA score and Lac+age+SOFA score to predict 28-day death in sepsis patients was 0.679, 0.626, 0.747, and 0.819, respectively. Conclusion: IL-6 is an independent predictor of sepsis diagnosis, and the combination of blood BUN and MAP has superior diagnostic performance. Lac, age, and SOFA score could effectively predict clinical outcomes in patients with sepsis.
- 21 September 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 5557-5566
Open AccessDiagnostic and Prognostic Value of Interleukin-6 in Emergency Department Sepsis Patients
Purpose: The objective of this study was to explore the diagnostic and prognostic value of interleukin-6 (IL-6) in sepsis patients presenting to the emergency department. Patients and Methods: A total of 128 patients who visited the emergency department of West Hospital of Beijing Chaoyang Hospital, affiliated to Capital Medical University, from November 2021 to February 2022 were subjected to this study. According to Sepsis-3.0 diagnostic criteria for sepsis, patients were divided into non-sepsis group (65 cases) and sepsis group (63 cases). Demographic data and clinical characteristics of the two patient groups were compared. Serum levels of biomarkers including IL-6, blood urea nitrogen (BUN), and lactic acid (Lac) were compared with Sequential Organ Failure Assessment (SOFA) and Glasgow Coma Scale (GCS) scores. Logistic regression was used to analyze independent risk factors and Receiver Operating Characteristic Curve (ROC) method was used to analyze the Area Under the Curve (AUC) to determine the diagnostic and prognostic value of markers. Results: Compared with non-sepsis patients, levels of IL-6, PCT, CRP and BUN were significantly higher in sepsis patients (10.84 (4.41– 27.01): 92.22 (21.53– 201.12), 0.03 (0.01– 0.1):0.49 (0.08– 3.1), 8.3 (0.5– 31.8):39.8(10.3– 98.6), 7.01 (4.90– 11.74):13.03 (6.93– 25.99), all p = 0.001). IL-6, BUN and mean arterial pressure (MAP) were independent risk factors for sepsis diagnosis. AUC values of IL-6, BUN, MAP and IL-6+BUN+MAP were 0.764, 0.696, 0.685, and 0.848, respectively. Lactate, age and SOFA score were independent risk factors for 28-day mortality in sepsis patients. The AUC of Lac, age, SOFA score and Lac+age+SOFA score to predict 28-day death in sepsis patients was 0.679, 0.626, 0.747, and 0.819, respectively. Conclusion: IL-6 is an independent predictor of sepsis diagnosis, and the combination of blood BUN and MAP has superior diagnostic performance. Lac, age, and SOFA score could effectively predict clinical outcomes in patients with sepsis.